About the 3rd LSX Nordic Congress
The LSX Nordic Congress is a high-calibre, senior executive conference and partnering event providing the education, strategies, solutions, and contacts that life science companies need to enable more effective investment, business planning and partnering within their businesses.
The Nordic region has long produced world-leading science and innovation and, now in its third year, the LSX Nordic Congress will be all about showcasing this innovation, both of the region's industry leaders but also through start-ups and technology innovators driving the future of healthcare.
Nasdaq Nordic is one of the leading hubs for life sciences in Europe, strengthened further by an active IPO market in the last few years, and we're delighted to be working again with Nasdaq as hosts of the congress. But this is not just for listed companies. This is the executive strategy, investment and partnering event for companies of all sizes, addressing challenges in their ongoing funding, growth, development and internationalisation.
With our growing international community of investors and pharma, our aim and mission is to bring investors to the Nordic region and connect Nordic executives with capital and partners, as well as peer-to-peer knowledge exchange.
Biotech, medtech and deeptech CxOs will be coming to Stockholm and joined by investors and pharma to address key issues facing their businesses and the wider healthcare sector.
1-2-1 partnering is a key focus across the two days. Pre-event all attendees and see who is attending, message each other and book meetings to find investors, investment opportunities and connect with potential partners.
Understand the latest trends, forecasts and insights from leading investors, life science executives, pharma BD&L heads and industry KOLs through presentations and more informal workshops and group discussions.